ArticleInternational journal of cancer2015

Serum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time.

Mi Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.